The 2024 ELN risk stratification was developed with evidence from an exploratory analysis of pooled data from the phase 3 VIALE-A trial and a phase 1 b study of azacitidine plus venetoclax.

The following is a summary of “Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation,” published in the December ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa. (HealthDay News) — For patients ...

The average age of people when they are first diagnosed with AML is about 69. AML is slightly more common among men than women, but the average lifetime risk of getting AML for both sexes is about ½ ...

This project has not set up a SECURITY.md file yet.

Abstract: Leukemia, a prevalent childhood cancer affecting the blood and bone marrow, necessitates a proactive approach to risk mitigation through lifestyle adaptations ... which was utilized for ...

Explore how pro-crypto policies are evolving, why banks are playing catch-up, and key strategies to get ahead in the digital ...

On January 9, 2025, the OECD published a new Policy Paper on the Tokenisation of Assets in Financial Markets, highlighting ...

Financial sector regulators have been urged to adopt a proactive approach in defining digital assets, especially ...